Investor results presentation

Inspiration Healthcare Group PLC

22 September 2023

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Investor results presentation

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in class, specialist neonatal intensive care medical devices, announces that the Company will provide a live presentation to investors via the Investor Meet Company platform on Friday, 6 October 2023 at 11am BST.

The presentation will give an update on the Company and an overview of the Group's interim results for the six months ended 31 July 2023 which will be issued on Tuesday, 3 October 2023, as stated in the recent trading update.  

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet Inspiration Healthcare.

To register for the presentation, please use this link:

https://www.investormeetcompany.com/inspiration-healthcare-group-plc/register-investor

Investors who already follow Inspiration Healthcare on the Investor Meet Company platform will automatically be invited.

For further information, please contact:

Inspiration Healthcare Group plc		Tel: +44  (0)330 175 0000
Neil Campbell, Chief Executive Officer
Alan Olby, Chief Financial Officer
Walbrook PR Ltd (Media and Investor Relations)	Tel: [phone] or [e-mail]
Anna Dunphy		Mob: [phone]
Stephanie Cuthbert		Mob: [phone]
Louis Ashe-Jepson		Mob: [phone]

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products.  The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.

With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex).  The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

 

END